详情页 - 聚合机构库演示平台

当前位置：首页 > 详情页

Suspected Adverse Drug Reactions in Pediatric Cancer Patients in China: An Analysis of Henan Province Spontaneous Reporting System Database (vol 11, 807171, 2021)

75| 认领 | 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

单位： [1]Huazhong Univ Sci & Technol, Sch Med & Hlth Management, Tongji Med Coll, Wuhan, Peoples R China [2]Huazhong Univ Sci & Technol, Tongji Hosp, Dept Pharm, Tongji Med Coll, Wuhan, Peoples R China [3]Med Prod Adm & Ctr Adverse Drug React ADR Monitor, Zhengzhou, Peoples R China [4]Huazhong Univ Sci & Technol, Coll Publ Adm, Wuhan, Peoples R China [5]Huazhong Univ Sci & Technol, Sch Pharm, Tongji Med Coll, Wuhan, Peoples R China

出处：

DOI：

ISSN：

关键词： pharmacovigilance drug monitoring adverse drug reaction reporting systems pediatric medical oncology

基金：

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2021]版：

大类 | 3 区医学

小类 | 3 区肿瘤学

最新[2025]版：

大类 | 3 区医学

小类 | 4 区肿瘤学

JCR分区：

出版当年[2020]版：

Q2 ONCOLOGY

最新[2023]版：

Q2 ONCOLOGY

影响因子： 3.5 最新[2023版] 4 最新五年平均 6.244 出版当年[2020版] 6.264 出版当年五年平均 4.848 出版前一年[2019版] 5.738 出版后一年[2021版]

第一作者：

第一作者单位： [1]Huazhong Univ Sci & Technol, Sch Med & Hlth Management, Tongji Med Coll, Wuhan, Peoples R China

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Suspected Adverse Drug Reactions in Pediatric Cancer Patients in China: An Analysis of Henan Province Spontaneous Reporting System Database [2]2010-2022年武汉市出血相关不良反应/事件分析 [3]Evidence-based Guideline for Therapeutic Drug Monitoring of Vancomycin: 2020 Update by the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society [4]A real-world disproportionality analysis of mepolizumab based on the FDA adverse event reporting system [5]Dose optimisation of voriconazole with therapeutic drug monitoring in children: a single-centre experience in China [6]Knowledge, Practices, and Perceived Barriers in Cancer Pain Management at Oncology Units: A Cross-Sectional Survey of Medical Staff in China [7]治疗药物监测的研究进展 [8]LC-MS/MS application for therapeutic drug monitoring for both TKIS and tri-azole antifungals in Chinese leukemia patients [9]儿童伏立康唑治疗药物浓度监测的临床意义 [10]基于伏立康唑血药浓度监测成功干预药物相互作用3例